These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10760339)

  • 1. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.
    Fonarow GC; Feliciano Z; Boyle NG; Knight L; Woo MA; Moriguchi JD; Laks H; Wiener I
    Am J Cardiol; 2000 Apr; 85(8):981-5. PubMed ID: 10760339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.
    Knight BP; Goyal R; Pelosi F; Flemming M; Horwood L; Morady F; Strickberger SA
    J Am Coll Cardiol; 1999 Jun; 33(7):1964-70. PubMed ID: 10362200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.
    Sweeney MO; Ruskin JN; Garan H; McGovern BA; Guy ML; Torchiana DF; Vlahakes GJ; Newell JB; Semigran MJ; Dec GW
    Circulation; 1995 Dec; 92(11):3273-81. PubMed ID: 7586314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death.
    Pappone C; Vicedomini G; Augello G; Mazzone P; Nardi S; Rosanio S
    Am J Cardiol; 2003 May; 91(9A):74F-80F. PubMed ID: 12729853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?
    Schmidinger H
    Am J Cardiol; 1999 Mar; 83(5B):151D-157D. PubMed ID: 10089858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ICD programming on inappropriate and appropriate ICD Therapies in ischemic and nonischemic cardiomyopathy: the MADIT-RIT trial.
    Sedláček K; Ruwald AC; Kutyifa V; McNitt S; Thomsen PEB; Klein H; Stockburger M; Wichterle D; Merkely B; DE LA Concha JF; Swissa M; Zareba W; Moss AJ; Kautzner J; Ruwald MH;
    J Cardiovasc Electrophysiol; 2015 Apr; 26(4):424-433. PubMed ID: 25546486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic study.
    Sánchez JM; Katsiyiannis WT; Gage BF; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Heart Rhythm; 2005 Apr; 2(4):367-73. PubMed ID: 15851337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
    Wever EF; Hauer RN; van Capelle FL; Tijssen JG; Crijns HJ; Algra A; Wiesfeld AC; Bakker PF; Robles de Medina EO
    Circulation; 1995 Apr; 91(8):2195-203. PubMed ID: 7697849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden death risk in syncope: the role of the implantable cardioverter defibrillator.
    Olshansky B; Sullivan RM
    Prog Cardiovasc Dis; 2013; 55(4):443-53. PubMed ID: 23472783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
    Silka MJ; Kron J; Dunnigan A; Dick M
    Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication.
    Saba S; Atiga WL; Barrington W; Ganz LI; Kormos RL; MacGowan GA; Mathier MA; McNamara DM; Obioha-Ngwu O; Murali S
    J Heart Lung Transplant; 2003 Apr; 22(4):411-8. PubMed ID: 12681418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.